Because NOX2 plays a fundamental role in the pathophysiology of TBI, the development of NCATS-SM7270 is an important step toward the eventual goal of targeting NOX as a therapeutic intervention for humans with brain injuries. The gene discussed is CYBB; the disease is brain injury.